UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 389

Sortiert nach

What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?

Gastroenterology (New York, N.Y. 1943), 2019-01, Vol.156 (2), p.446-460.e2

2019

Link zum Volltext

Verfügbarkeit prüfen

Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights

Nature reviews. Gastroenterology & hepatology, 2016-06, Vol.13 (6), p.338

2016

Link zum Volltext

Verfügbarkeit prüfen

The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver

Canadian Medical Association journal (CMAJ), 2018-06, Vol.190 (22), p.E677

2018

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells

The Journal of clinical investigation, 2023-01, Vol.133 (1), p.1-16

2023

Link zum Volltext

Verfügbarkeit prüfen

Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity

Nature communications, 2022-11, Vol.13 (1), p.6992-6992, Article 6992

2022

Link zum Volltext

Verfügbarkeit prüfen

Ribavirin potentiates interferon action by augmenting interferon‐stimulated gene induction in hepatitis C virus cell culture models

Hepatology (Baltimore, Md.), 2011-01, Vol.53 (1), p.32-41

2011

Link zum Volltext

Verfügbarkeit prüfen

Implications of Manganese in Chronic Acquired Hepatocerebral Degeneration

Annals of hepatology, 2019, Vol.18 (1), p.274-278

2019

Link zum Volltext

Verfügbarkeit prüfen

Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion

Nature communications, 2019-01, Vol.10 (1), p.481-481, Article 481

2019

Link zum Volltext

Verfügbarkeit prüfen

Ribavirin revisited in the era of direct‐acting antiviral therapy for hepatitis C virus infection

Liver international, 2017-01, Vol.37 (1), p.5-18

2017

Link zum Volltext

Verfügbarkeit prüfen

Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus

Proceedings of the National Academy of Sciences - PNAS, 2023-06, Vol.120 (24), p.e2220294120-e2220294120

2023

Link zum Volltext

Verfügbarkeit prüfen

What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?

The Journal of infectious diseases, 2024-05, Vol.229 (Supplement_3), p.S316-S321

Feld, Jordan J

2024

Link zum Volltext

Verfügbarkeit prüfen

Extending a Helping Hand: Addressing Hepatitis C in Economic Migrants and Refugees

Annals of hepatology, 2018, Vol.17 (1), p.8-10

Feld, Jordan J

2018

Link zum Volltext

Verfügbarkeit prüfen

What Comes First: Treatment of Viral Hepatitis or Liver Cancer?

Digestive diseases and sciences, 2019-04, Vol.64 (4), p.1041-1049

2019

Link zum Volltext

Verfügbarkeit prüfen

Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients

Hepatology (Baltimore, Md.), 2012-01, Vol.55 (1), p.39-48

2012

Link zum Volltext

Verfügbarkeit prüfen

Race or genetic makeup for hepatitis C virus treatment decisions?

Hepatology (Baltimore, Md.), 2017-06, Vol.65 (6), p.2124-2125

2017

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune hepatitis : Effect of symptoms and cirrhosis on natural history and outcome

Hepatology (Baltimore, Md.), 2005-07, Vol.42 (1), p.53-62

2005

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study

Clinical infectious diseases, 2016-09, Vol.63 (6), p.776-783

2016

Link zum Volltext

Verfügbarkeit prüfen

Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020

Hepatology communications, 2021-06, Vol.5 (6), p.911-922

2021

Link zum Volltext

Verfügbarkeit prüfen

Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression

Journal of virology, 2016-06, Vol.90 (12), p.5549-5560

2016

Link zum Volltext

Verfügbarkeit prüfen

Long‐term follow‐up of antimitochondrial antibody–positive autoimmune hepatitis

Hepatology (Baltimore, Md.), 2008-08, Vol.48 (2), p.550-556

2008

Link zum Volltext

Verfügbarkeit prüfen

Sorting out cirrhosis: mechanisms of non-response to hepatitis C therapy

Liver international, 2015-08, Vol.35 (8), p.1923-1933

2015

Link zum Volltext

Verfügbarkeit prüfen

Plasma interferon‐gamma‐inducible protein‐10 (IP‐10) levels during acute hepatitis C virus infection

Hepatology (Baltimore, Md.), 2013-06, Vol.57 (6), p.2124-2134

2013

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants

BMC public health, 2020-09, Vol.20 (1), p.1345-1345, Article 1345

2020

Link zum Volltext

Verfügbarkeit prüfen

HCV elimination: It will take a village and then some

Journal of hepatology, 2020-04, Vol.72 (4), p.601-603

Feld, Jordan J.

2020

Link zum Volltext

Verfügbarkeit prüfen

Absolute Ligand Discrimination by Dimeric Signaling Receptors

Biophysical journal, 2016-09, Vol.111 (5), p.917-920

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 389

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

SpracheSpanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(374)
Mit Volltextzugriff
(360)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(253)
Life Sciences & Biomedicine
(246)
Humans
(175)
Gastroenterology & Hepatology
(155)
Male
(93)
Female
(92)
Hepatitis C
(78)
Middle Aged
(74)
Antiviral Agents - Therapeutic Use
(71)
Hepatitis
(69)
Adult
(67)
Infectious Diseases
(61)
Hepatitis C, Chronic - Drug Therapy
(53)
Hepatitis C Virus
(48)
Hepatitis B
(45)
Interferon
(42)
Infections
(41)
Hepatology
(39)
Aged
(38)
Antiviral Agents
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?

Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights

The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver

Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells

Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity

Ribavirin potentiates interferon action by augmenting interferon‐stimulated gene induction in hepatitis C virus cell culture models

Implications of Manganese in Chronic Acquired Hepatocerebral Degeneration

Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion

Ribavirin revisited in the era of direct‐acting antiviral therapy for hepatitis C virus infection

Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus

What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?

Extending a Helping Hand: Addressing Hepatitis C in Economic Migrants and Refugees

What Comes First: Treatment of Viral Hepatitis or Liver Cancer?

Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients

Race or genetic makeup for hepatitis C virus treatment decisions?

Autoimmune hepatitis : Effect of symptoms and cirrhosis on natural history and outcome

Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study

Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020

Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression

Long‐term follow‐up of antimitochondrial antibody–positive autoimmune hepatitis

Sorting out cirrhosis: mechanisms of non-response to hepatitis C therapy

Plasma interferon‐gamma‐inducible protein‐10 (IP‐10) levels during acute hepatitis C virus infection

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants

HCV elimination: It will take a village and then some

Absolute Ligand Discrimination by Dimeric Signaling Receptors

Aktive Filter

Suchergebnisse filtern